Metabolomics-Guided Hypothesis Generation for Mechanisms of Intestinal Protection by Live Biotherapeutic Products

The use of live biotherapeutic products (LBPs), including single strains of beneficial probiotic bacteria or consortiums, is gaining traction as a viable option to treat inflammatory-mediated diseases like inflammatory bowel disease (IBD). However, LBPs’ persistence in the intestine is heterogeneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Jiayu, Erland, Lauren A. E., Gill, Sandeep K., Bishop, Stephanie L., Verdugo-Meza, Andrea, Murch, Susan J., Gibson, Deanna L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156236/
https://www.ncbi.nlm.nih.gov/pubmed/34063522
http://dx.doi.org/10.3390/biom11050738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156236/
https://www.ncbi.nlm.nih.gov/pubmed/34063522
http://dx.doi.org/10.3390/biom11050738

Ejemplares similares